ENCE Energía y Celulosa S.A (ENC)
Madrid Stock Exchange · Spain · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 2.234 |
|---|---|
| 52-week range | 2.140 – 2.748 |
| Return, 1 month / 3 months | −7.7% / −11.7% |
| Return, 1 year / 3 years | −17.3% / −23.0% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 26.2% |
| Worst drawdown (1 year) | -19.0% |
| Average daily value traded | 0.54M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ence Energía y Celulosa is a Spanish industrial company based in Madrid. It produces bleached eucalyptus kraft pulp, which it supplies to makers of paper and tissue products, and it also generates renewable electricity, chiefly from biomass, at its facilities. Its operations combine pulp manufacturing with power generation, and its customers are mainly industrial buyers of pulp and electricity in Spain and other markets.
ENCE Energía y Celulosa S.A trades under the code ENC on the Madrid Stock Exchange in Spain, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ENCE Energía y Celulosa S.A (ENC) trades on the Madrid Stock Exchange in Spain. It last closed at EUR 2.234 on 27 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 147 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 17.3% and over the last three months it fell 11.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 41 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.9% | ||
| From 52-week high | -17.3% | ||
| Momentum | 31 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.7% | ||
| 6-month return | -4.7% | ||
| 12-month return, skipping the last month | -10.4% | ||
| Stability (higher is calmer) | 49 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.0% | ||
| Liquidity | 72 · Strong | Trades actively. | |
| Average daily value traded | 0.54M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.9% |
|---|---|
| 1 month | −7.7% |
| 3 months | −11.7% |
| 6 months | −4.7% |
| 1 year | −17.3% |
| 3 years | −23.0% |
| 5 years | +34.4% |
Signals
| 50-day / 200-day average | 2.393 / 2.400 |
|---|---|
| Golden / death cross (60 days) | Death, 1 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.058 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Nov 2024 | EUR 0.0267 |
| 5 Aug 2024 | EUR 0.0867 |
| 16 May 2023 | EUR 0.2349 |
| 14 Mar 2023 | EUR 0.2349 |
| 11 Nov 2022 | EUR 0.0729 |
| 10 Aug 2022 | EUR 0.1053 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.